Member News
-
Valeo Pharma Secures Additional Public Reimbursement for Redesca™, Enerzair® Breezhaler® and Atectura® Breezhaler®
Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia Enerzair Breezhaler and Atectura Breezhaler…
-
Awakn Life Sciences Announces Closing of Private Placement
March 22, 2022 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”),…
-
Zentek To Begin Trading Common Stock on NASDAQ March 22, 2022
March 21, 2022 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK; TSX-V:ZEN; and OTC PINK:ZENYF), a Canadian intellectual property…
-
Ideanomics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
March 18, 2022 (Source) — Ideanomics (NASDAQ: IDEX) (“Ideanomics” or the “Company”) today announced that it has received a notice (the…
-
ePlay Digital CEO To Participate In Mass Participation World Sports Metaverse Panel
Registration open for WEB3.0, The Metaverse and Mass Participation Panel – Mar 31, 2022 March 18, 2022 (Source)…
-
Maiden Drilling Commences at Halleck Creek After 308 – 385 Million Tonne Exploration Target Defined
ARR-Maiden-Drilling-at-Halleck-Creek-V2.1.pdf
-
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
London Clinic Will Begin Delivering Ketamine-Assisted Therapy for Addiction & Mental Health Third Location Adds to Two Existing…
